Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P47
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Datta, Jashodeep
Xu, Shuwen
Terhune, Julia H
Rosemblit, Cinthia
Berk, Erik
Fitzpatrick, Elizabeth
Czerniecki, Brian J
Article History
First Online: 6 November 2014